Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager

Authors

Linda G. Eissenberg, Washington University School of Medicine in St. Louis
Julie K. Ritchey, Washington University School of Medicine in St. Louis
Michael P. Rettig, Washington University School of Medicine in St. Louis
Dilan A. Patel, Washington University School of Medicine in St. Louis
Kiran Vij, Washington University School of Medicine in St. Louis
Feng Gao, Washington University School of Medicine in St. Louis
Victoria Smith, Amphivena Therapeutics, Inc.
Tae H Han, Amphivena Therapeutics, Inc.
John F. DiPersio, Washington University School of Medicine in St. Louis

Journal

PLoS One

Publication Date

1-1-2024

Volume

19

Issue

5

First Page

e0300174

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0300174

Rights and Permissions

Eissenberg LG, Ritchey JK, Rettig MP, Patel DA, Vij K, Gao F, Smith V, Han TH, DiPersio JF. Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager. PLoS One. 2024 May 2;19(5):e0300174. doi: 10.1371/journal.pone.0300174. © 2024 Eissenberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Eissenberg, Linda G.; Ritchey, Julie K.; Rettig, Michael P.; Patel, Dilan A.; Vij, Kiran; Gao, Feng; Smith, Victoria; Han, Tae H; and DiPersio, John F., "Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager." PLoS One. 19, 5. e0300174 (2024).
https://digitalcommons.wustl.edu/oa_4/3901

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.